BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 21275849)

  • 1. The molecular pathogenesis and management of bronchial carcinoids.
    Cakir M; Grossman A
    Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
    Wolin EM
    Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic therapy for pulmonary carcinoids.
    Marquez-Medina D; Popat S
    Lung Cancer; 2015 Nov; 90(2):139-47. PubMed ID: 26371699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Well-differentiated neuroendocrine carcinomas: the spectrum of histologic subtypes and various clinical behaviors.
    Warren WH; Welker M; Gattuso P
    Semin Thorac Cardiovasc Surg; 2006; 18(3):199-205. PubMed ID: 17185179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary neuroendocrine/carcinoid tumors: a review article.
    Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
    Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine tumors: analysis of 252 cases].
    Chi YH; Jiang WC; Du F; Sun YK; Song Y; Yang L; Zhou AP; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):67-70. PubMed ID: 23648305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
    Sun TY; Hendifar A; Padda SK
    Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
    Warren WH; Gould VE; Faber LP; Kittle CF; Memoli VA
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):819-25. PubMed ID: 2582209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
    Travis WD
    Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
    Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
    Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Well-differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients.
    Pericleous M; Karpathakis A; Toumpanakis C; Lumgair H; Reiner J; Marelli L; Thirlwell C; Caplin ME
    Clin Respir J; 2018 Mar; 12(3):904-914. PubMed ID: 28026127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas.
    Yoshimoto T; Motoi N; Yamamoto N; Nagano H; Ushijima M; Matsuura M; Okumura S; Yamaguchi T; Fukayama M; Ishikawa Y
    Neuroendocrinology; 2018; 106(1):47-57. PubMed ID: 28208131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.